Grafton, WI, United States of America

Sara LeBrun-Blashka


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sara LeBrun-Blashka in Digestive Health

Introduction

Sara LeBrun-Blashka is an accomplished inventor based in Grafton, Wisconsin. She has made significant contributions to the field of digestive health through her innovative research and patenting efforts. Her work focuses on developing compositions and methods that manage digestive disorders and promote a healthy microbiome.

Latest Patents

Sara holds a patent for her invention titled "Compositions and methods for managing digestive disorders and a healthy microbiome." This patent discloses a prebiotic composition that includes a combination of 2'fucosyllactose (2'FL) and isomaltooligosaccharide (IMO). The composition is effective in preventing and treating gastrointestinal conditions in animals, such as irritable bowel syndrome (IBS), inflammatory bowel diseases (IBD), Crohn's disease, and ulcerative colitis (UC). The patent also describes various applications of the prebiotic composition, including its use in foodstuffs, medical foods, nutritional compositions, and kits designed to reduce inflammation in the gastrointestinal tract.

Career Highlights

Sara is currently associated with Metagenics, Inc., where she continues to advance her research in digestive health. Her innovative approach and dedication to improving gastrointestinal health have positioned her as a key figure in her field.

Collaborations

Sara collaborates with notable colleagues, including John Troup and Nikhat Contractor, who contribute to her research endeavors and help bring her innovative ideas to fruition.

Conclusion

Sara LeBrun-Blashka's work exemplifies the impact of innovation in the field of digestive health. Her patented compositions and methods are paving the way for new treatments and improved health outcomes for individuals suffering from gastrointestinal disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…